Inactive Instrument

Sector ratings Galapagos NV Euronext Bruxelles

Stocks

End-of-day quote Euronext Bruxelles Other stock markets
-	-

06-16	Lakefront Biotherapeutics NV commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 28, 2026.	CI
06-10	Lakefront Announces Share Buyback Program

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Consensus
GALAPAGOS NV	1.86B	-	B	-	-
LONZA GROUP AG	43.13B		AAA
REVOLUTION MEDICINES, INC.	34.65B	-	B	-	-
BEONE MEDICINES AG	30.03B		-
IQVIA HOLDINGS INC.	28B		AAA
CELLTRION, INC.	24.45B		A
ASCENDIS PHARMA A/S	14.34B	-	-	-	-	-
MEDPACE HOLDINGS, INC.	13.14B		BBB
EUROFINS SCIENTIFIC SE	12.53B		AA
IONIS PHARMACEUTICALS, INC.	12.25B	-	A	-	-
ICON PUBLIC LIMITED COMPANY	11.18B		AAA
TEMPUS AI, INC.	9.13B		A		-
BIO-TECHNE CORPORATION	9.07B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	8.91B		AA
PRAXIS PRECISION MEDICINES, INC.	7.87B	-	B	-	-
ABIVAX	7.77B	-	BBB	-	-
QIAGEN N.V.	7.64B		AAA
ALKERMES PLC	7.5B		A
KYMERA THERAPEUTICS, INC.	7.44B	-	BBB	-	-
PROTAGONIST THERAPEUTICS, INC.	7.26B		BB		-
Average	15.59B		A
Weighted average by Cap.			A